Reported about 13 hours ago
Health and pharmaceutical stocks, including Moderna, Pfizer, BioNTech, and Novavax, are experiencing a decline following Robert F. Kennedy Jr.'s successful vote in the Senate Finance Committee regarding his nomination for the Secretary of Health and Human Services. His controversial views on healthcare, particularly vaccines, are causing market concerns as his nomination advances to a full Senate vote.
Source: YAHOO